Literature DB >> 16807742

[Expression und function of the ORL-1 receptor on human leukocytes].

C Krüger1, L Köthe, A Struppert, C Pietruck, A Simm, S Grond.   

Abstract

BACKGROUND: The ORL-1 receptor is expressed by human leukocytes. Limited knowledge exists about the function and interaction between the nervous and immune systems. The aim of our study was to investigate the expression of the nociceptin-ORL-1 receptor system on different leukocyte subsets and the influence of the ORL-1 receptor on the intracellular production of cytokines.
METHODS: Blood from healthy volunteers of different age and sex was analysed for the expression of the ORL-1 receptor by PCR and flow cytometry and the influence of nociceptin on the LPS-induced production of intracellular cytokines by flow cytometry.
RESULTS: The ORL-1 receptor mRNA is expressed by granulocytes, lymphocytes and monocytes. We could also show the expression of the ORL-1 receptor protein on the cell surface of all types of white blood cells. Nociceptin has no influence on LPS-induced cytokine production in human monocytes. There was neither a difference between young and old nor between male or female volunteers.
CONCLUSION: The ORL-1 receptor is expressed by all subtypes of leukocytes. The function of this receptor is not the modulation of cytokine production and requires further studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807742     DOI: 10.1007/s00482-006-0488-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  27 in total

1.  Immunofluorescence detection of delta opioid receptors (DOR) on human peripheral blood CD4+ T cells and DOR-dependent suppression of HIV-1 expression.

Authors:  B M Sharp; K McAllen; G Gekker; N A Shahabi; P K Peterson
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

Review 2.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

Review 3.  Leukocytes in the regulation of pain and analgesia.

Authors:  H L Rittner; H Machelska; C Stein
Journal:  J Leukoc Biol       Date:  2005-10-04       Impact factor: 4.962

4.  Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4.

Authors:  C N Serhan; I M Fierro; N Chiang; M Pouliot
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

5.  Orphanin FQ/nociceptin binds to functionally coupled ORL1 receptors on human immune cell lines and alters peripheral blood mononuclear cell proliferation.

Authors:  J Peluso; C Gavériaux-Ruff; H W Matthes; D Filliol; B L Kieffer
Journal:  Brain Res Bull       Date:  2001-04       Impact factor: 4.077

6.  Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain.

Authors:  H L Rittner; A Brack; H Machelska; S A Mousa; M Bauer; M Schäfer; C Stein
Journal:  Anesthesiology       Date:  2001-08       Impact factor: 7.892

7.  Functional role and sequence analysis of a lymphocyte orphan opioid receptor.

Authors:  W P Halford; B M Gebhardt; D J Carr
Journal:  J Neuroimmunol       Date:  1995-06       Impact factor: 3.478

8.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

9.  Human neutrophils as a source of nociceptin: a novel link between pain and inflammation.

Authors:  Marie-Elaine Fiset; Caroline Gilbert; Patrice E Poubelle; Marc Pouliot
Journal:  Biochemistry       Date:  2003-09-09       Impact factor: 3.162

10.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.

Authors:  J C Meunier; C Mollereau; L Toll; C Suaudeau; C Moisand; P Alvinerie; J L Butour; J C Guillemot; P Ferrara; B Monsarrat
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

View more
  4 in total

1.  Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro.

Authors:  Benito Anton; Phillipe Leff; Joseph J Meissler; Juan C Calva; Rodolfo Acevedo; Alberto Salazar; Maura Matus; Anabel Flores; Martin Martinez; Martin W Adler; John P Gaughan; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-02       Impact factor: 4.147

2.  Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease.

Authors:  Chunshuang Xu; Guili Liu; Huihui Ji; Weihua Chen; Dongjun Dai; Zhongming Chen; Dongsheng Zhou; Lei Xu; Haochang Hu; Wei Cui; Lan Chang; Qin Zha; Liping Li; Shiwei Duan; Qinwen Wang
Journal:  Mol Med Rep       Date:  2018-08-24       Impact factor: 2.952

3.  Inflammatory mediators influence the expression of nociceptin and its receptor in human whole blood cultures.

Authors:  Lan Zhang; Frank Stuber; Ulrike M Stamer
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

4.  Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor.

Authors:  M F Bird; R Guerrini; J M Willets; J P Thompson; G Caló; D G Lambert
Journal:  Br J Pharmacol       Date:  2018-11-06       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.